Diabetic Gastroparesis Treatment Market Analysis-2027

1. DIABETIC GASTROPARESIS TREATMENT MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Diabetic Gastroparesis Treatment Market Analysis - Overview Inherent damage in vagus nerve that controls the movement of food through the digestive tract is a major cause of diabetic gastroparesis. Damage in the vagus nerve leads to malfunctioning of muscles of the stomach and intestines and the movement of food is slowed or stopped. The global Diabetic Gastroparesis Treatment Market is estimated to account for US$ 3,069.8 Mn in terms of value in 2018 and is expected to reach US$ 4,252.2 Mn by the end of 2027. Global Diabetic Gastroparesis Treatment Market: Drivers Development of effective therapeutics for the treatment of diabetic gastroparesis is expected to propel growth of the global diabetic gastroparesis treatment market over the forecast period. For instance, according to research presented at Digestive Disease Week, a medical meetings by Healthcare Convention & Exhibitors Association (HCEA), in June 2019, Velusetrag, an oral, highly selective 5-hydroxytryptamine receptor 4 agonist, effectively reduced symptoms and gastric emptying in patients with diabetic or idiopathic gastroparesis. Global Diabetic Gastroparesis Treatment Market: Opportunities Developments in endoscopic ultrasonography are expected to offer lucrative growth opportunities for players in the global diabetic gastroparesis treatment market. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/diabetic- gastroparesis-treatment-market-3603 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Global Diabetic Gastroparesis Treatment Market: Restraints The reported incidence of diabetic gastroparesis is very low worldwide as the symptoms are common with general nausea, vomiting, and gastroesophageal reflux disease. Furthermore, the use of non-prescription drugs for the treatment of the symptoms of the disease restricts diagnosis of stage 1 and stage 2 gastroparesis. Such factors are also expected to propel growth of the global diabetic gastroparesis market. Key Takeaways: Drugs segment in the global diabetic gastroparesis treatment market was valued at US$ 1,924.5 Mn in 2018 and is expected to reach US$ 2,646.8 Mn by 2027 at a CAGR of 3.6% during the forecast period. Drugs are the first choice of treatment for any kind of ailment, and surgical options are often used when pharmacological treatment is not producing any results or the disease has become life threatening. Patients as well as physicians are expected to prefer treatments with drugs as first line therapy which is expected to support growth of the market. The hospital pharmacies segment held dominant position in the global diabetic gastroparesis treatment market in 2018, accounting for 48.4% share in terms of value, followed by retail pharmacies and online pharmacies, respectively. Patients are expected to visit hospitals frequently for routine check-ups as well as to renew their prescriptions and later buy the medicines from hospital pharmacies. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/3603 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Moreover, in countries in Asia Pacific regions patients often buy medicines from hospital pharmacies itself. These factors are expected to support growth of the segment over the forecast period. The Antiemetic Agents segment held dominant position in the global diabetic gastroparesis treatment market in 2018, accounting for 53.8% share in terms of value, followed by gastroprokinetic agents, and botulinum toxin, respectively. Factors such as widespread presence of cheaper generic antiemetic agents, easy availability of drugs in pharmacies, and large number of manufacturers is expected to support growth of the segment. Market Trends Gastric electrical stimulation can be used for the treatment of diabetic gastroparesis. For instance, in November 2019, researchers from University of Louisville reported that gastric electrical stimulation is beneficial for improving the treatment of diabetic gastroparesis. Players in the market are focused on raising funds. For instance, in January 2018, Neurogastrx raised US$ 45 million for building its management team. The company’s drug candidate, NG-101, is designed for the treatment of gastroparesis. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3603 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved